This past winter, hospitals and clinics across Indiana filled up with patients suffering from different respiratory illnesses that have much the same symptoms: COVID-19, flu and RSV. And many more ...
New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a single patient sample on the high throughput molecular diagnostic analysers ...
Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...
PLEASANTON, Calif., Oct. 29, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval of expanded claims for the cobas® EGFR Mutation ...
On Wednesday morning before the opening bell, Roche announced they will launch in late September a new Rapid Antigen Test development for the detection of Severe Acute Respiratory Syndrome COV-2 (SARS ...
The rollout comes amid long lines at testing sites and President Joe Biden's promise to increase the number of tests available. Healthcare giant Roche will roll out "tens of millions" of at-home Covid ...
INDIANAPOLIS, Feb. 8, 2021 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the submission for Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for ...
Dec. 9 (UPI) --Swiss healthcare company Roche announced Wednesday its newly approved coronavirus antibody test will be used in clinical trials for the COVID-19 vaccine developed by Moderna. The U.S.
Basel, 24 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its COVID-19 At-Home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback